Literature DB >> 821947

Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC.

Y Furuichi, S Muthukrishnan, J Tomasz, A J Shatkin.   

Abstract

Blocked and methylated 5' termini of reovirus mRNA are formed by viral cores at an early stage of transcription. Cores incubated in a complete transcription reaction mixture for 30 s, or in a mixture lacking UTP and ATP for a longer time, synthesize the "cap" structure, m7GpppGmpC. The dinucleotide ppGpC functions as substrate for a core-associated guanylyltransferase and is converted to GpppGpC by addition of pG from GTP. For optimal conversion, both the diphosphate terminus and phosphodiester bond are required. pGpC is not a substrate, but pppGpC is utilized after removal of the gamma-phosphate by a core nucleotide phospohydrolase. Methyltransferases also present in cores transfer methyl groups sequentially from S-adenosylmethionine (AdoMet) to the N7-position of the 5'-terminal guanosine followed by the 2'-OH of the penultimate guanosine. GpppGpC is hydrolyzed by cores in the presence of pyrophosphate to ppGpC, the predominant 5'-terminal structure of reovirus mRNA made in the absence of S-adenosylmethionine. N7-methylation prevents pyrophosphorolysis of m7GpppGpC, which may explain the increased proportion of blocked, methylated 5' termini in viral mRNA synthesized in the presence of S-adenosylmethionine. On the basis of these findings, the following reaction series is proposed for the synthesis of reovirus mRNA caps. In the series, AdoHcy is the abbreviation for S-adenosylhomocysteine (see article)9

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821947

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Identification and characterization of a transcription pause site in rotavirus.

Authors:  J A Lawton; M K Estes; B V Prasad
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Reovirus sigma NS protein localizes to inclusions through an association requiring the mu NS amino terminus.

Authors:  Cathy L Miller; Teresa J Broering; John S L Parker; Michelle M Arnold; Max L Nibert
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Structure of the guanylyltransferase domain of human mRNA capping enzyme.

Authors:  Chun Chu; Kalyan Das; James R Tyminski; Joseph D Bauman; Rongjin Guan; Weihua Qiu; Gaetano T Montelione; Eddy Arnold; Aaron J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

4.  The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry.

Authors:  Kartik Chandran; John S L Parker; Marcelo Ehrlich; Tomas Kirchhausen; Max L Nibert
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 5.  An unconventional pathway of mRNA cap formation by vesiculoviruses.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

6.  Heterogeneity of the 5' terminus of late mRNA induced by a viable simian virus 40 deletion mutant.

Authors:  G Haegeman; H van Heuverswyn; D Gheysen; W Fiers
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

Review 7.  In vitro capping and transcription of rhabdoviruses.

Authors:  Tomoaki Ogino
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

8.  Chemical synthesis of 5'-pyrophosphate and triphosphate derivatives of 3'-5' ApA, ApG, GpA and GpG. CD study of the effect of 5'-phosphate groups on the conformation of 3'-5' GpG.

Authors:  J Tomasz; A Simoncsits; M Kajtár; R M Krug; A J Shatkin
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

Review 9.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

10.  Probing the transcription mechanisms of reovirus cores with molecules that alter RNA duplex stability.

Authors:  Alexander A Demidenko; Max L Nibert
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.